# FDA Inspection 820781 - Biomat USA, Inc - March 01, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7005f9d8-70ed-40ac-b594-e8576f74e62b
Source feed: FDA_Inspections

> FDA Inspection 820781 for Biomat USA, Inc on March 01, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 820781
- Company Name: Biomat USA, Inc
- Inspection Date: 2013-03-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1059784 - 2018-07-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/25aa10c2-beeb-44d2-90b5-98f49a62c040)
- [FDA Inspection 944193 - 2015-09-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/53949a91-31f1-4d60-9622-4f35f646b885)
- [FDA Inspection 694733 - 2010-10-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ec8d49a9-5940-43eb-9da3-26a94958bcf9)

Company: https://www.keypedia.com/companies/biomat-usa-inc/fd20eee1-ba98-44a4-b2b1-34815cc12fd6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d